l9n/ Mississippi

2021 Regular Session

Senate Bill 2278

Uniform Controlled Substances Act; revise schedules.

Did not become law. It stopped in the House of Representatives's Drug Policy Committee on March 2, 2021. The 2021 session has ended.

What it does

The synopsis the Legislature published with the bill.

AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, TO INCLUDE ISOTONITAZENE, FLUALPRAZOLAM, FLUBROMAZEPAM, FLUBROMAZOLAM AND CLONAZOLAM TO SCHEDULE I BECAUSE THESE DRUGS HAVE NO LEGITIMATE MEDICAL USE AND HAVE HIGH POTENCY WITH GREAT POTENTIAL TO CAUSE HARM; TO AMEND SECTION 41-29-115, MISSISSIPPI CODE OF 1972, TO REVISE THE CHEMICAL NAME OF THIAFENTANIL; TO AMEND SECTION 41-29-119, MISSISSIPPI CODE OF 1972, TO INCLUDE BREXANOLONE AND SOLRIAMFETOL AS SCHEDULE IV CONTROLLED SUBSTANCES BECAUSE THE FEDERAL DRUG ADMINISTRATION RECENTLY APPROVED THESE DRUGS FOR MEDICAL USE; AND FOR RELATED PURPOSES.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

2 co-sponsors

Robert L. Jackson, Joseph Thomas

Its course

January 12 to March 2, 2021, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action6 actions on 6 days

In the SenateJan 12 to Feb 423 days

Drug PolicyJan 12 to Jan 2614 days

In the House of RepresentativesFeb 4 to Mar 2 · stopped26 days

Drug PolicyFeb 23 to Mar 2 · stopped7 days

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the Senate Jan 12 – Feb 4

  1. Referred to the Senate committee on Drug Policy
  2. Reported from committee in the Senate: title sufficient, do pass
  3. Passed the Senate

In the House of Representatives Feb 5 – Mar 2

  1. Sent to the House
  2. Referred to the House committee on Drug Policy
  3. Died in committee in the House
All 6 actions, as published